Continuous glucose monitoring (CGM) identified four distinct glycaemic phenotypes among older adults with Type 2 diabetes; each associated with different metabolic characteristics and cardiovascular-kidney-metabolic (CKM) syndrome profiles.
Researchers found that the phenotype characterised by high glucose exposure, but relatively low glucose variability had the strongest association with advanced CKM syndrome, despite not having the poorest overall glycaemic control.
Identifying Distinct Glycaemic Phenotypes
Researchers analysed clinical, biochemical, and CGM data from 2,491 adults aged 60 years or older with Type 2 diabetes. Participants had maintained stable glucose-lowering treatment regimens for the preceding three months and underwent seven days of blinded CGM monitoring.
CKM syndrome was classified according to American Heart Association criteria, with Stages 3 and 4 considered advanced disease. Overall, 65.0% of participants had advanced CKM syndrome.
Participants were divided into four phenotypes according to whether their TAR and MAGE measurements were above or below the study population’s median values of 27.0% and 5.3 mmol/L, respectively.
High Glucose Exposure and Low Variability Show Strongest Association
Participants with both high TAR and high MAGE had the poorest overall glycaemic control, including the highest median HbA1c of 9.1% and the lowest time in range.
However, the high TAR and low MAGE phenotype showed the highest prevalence of advanced CKM syndrome, at 73.3%. This group also demonstrated a fasting hyperglycaemia-dominant pattern, with the highest fasting plasma glucose and triglyceride levels, alongside the lowest insulin sensitivity among the four groups.
Further Research Needed to Validate Findings
Researchers suggested that CGM-derived phenotypes may help characterise metabolic heterogeneity that is not fully captured by conventional glycaemic indicators.
Researchers concluded that CGM-derived glycaemic phenotypes may provide additional information for understanding metabolic differences and their association with advanced CKM syndrome in older adults with Type 2 diabetes. Prospective studies are needed to assess their value in predicting CKM progression and cardiorenal outcomes.
Reference:
Su H et al. Continuous glucose monitoring-derived glycemicphenotypes reflect metabolic heterogeneity linked toadvanced cardiovascular-kidney-metabolic syndrome inolder adults with type 2 diabetes. Journal of Diabetes.2026; DOI: 10.1111/1753-0407.70298.